Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Weighing the Options and Managing the Patient With RA Refractory to Treatment
Link ID 11632
Title Weighing the Options and Managing the Patient With RA Refractory to Treatment
Url http://www.medscape.com/viewprogram/17783?src=rss
Description Join Dr. Kay in an in-depth discussion of the latest advances in mechanism-based treatment options for patients with RA who are refractory to treatment. Medscape Rheumatology
Category Articles > Rheumatology
Keywords
Date Dec 17, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Rheumatology
1. Tocilizumab: The First Interleukin-6-Receptor Inhibitor
  Tocilizumab, a novel IL-6R inhibitor, may be beneficial for the treatment of RA in patients who do not respond to methotrexate or disease-modifying antirheumatic drugs.
American Journal of Health-System Pharmacy
Category:   Articles > Rheumatology


2. New Biologic for Treating Rheumatoid Arthritis: Clinical Trial Experience With Tocilizumab
  Tocilizumab, the first IL-6 receptor antagonist, has demonstrated efficacy in patients with moderate to severe RA refractory to anti-TNF therapy. International Journal of Clinical Rheumatology
Category:   Articles > Rheumatology


3. Meniscal Tears in Osteoarthritis: Ignore or Operate?
  In this video blog, Dr. Elizabeth Tindall presents the case of a 63-year-old man who injured his knee, leading her to review the literature on whether meniscal surgery should be recommended. Medscape Rheumatology
Category:   Articles > Rheumatology


4. Naproxen, Prednisolone May Be Effective First-Line Treatment of Gout
  In a randomized controlled trial, oral prednisolone and naproxen were equally effective in the initial treatment of gouty arthritis at 4 days. Medscape Medical News
Category:   Articles > Rheumatology


5. Infliximab Stops Bone Loss at Hip, but Not Spine or Hand, in Early Rheumatoid Arthritis
  In patients with active early rheumatoid arthritis (RA), adding infliximab to methotrexate can arrest bone loss at the hip, but not at the spine or hand, researchers report in the Annals of the Rheumatic Diseases for December. Reuters Health Information
Category:   Articles > Rheumatology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS